1. Home
  2. SND vs CNTN Comparison

SND vs CNTN Comparison

Compare SND & CNTN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Smart Sand Inc.

SND

Smart Sand Inc.

HOLD

Current Price

$5.21

Market Cap

208.5M

Sector

Industrials

ML Signal

HOLD

CNTN

Canton Strategic Holdings Inc. Common Stock

N/A

Current Price

$3.23

Market Cap

184.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SND
CNTN
Founded
2011
2017
Country
United States
United States
Employees
318
3
Industry
Mining & Quarrying of Nonmetallic Minerals (No Fuels)
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
208.5M
184.2M
IPO Year
2016
2022

Fundamental Metrics

Financial Performance
Metric
SND
CNTN
Price
$5.21
$3.23
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
398.1K
487.5K
Earning Date
05-12-2026
05-11-2026
Dividend Yield
3.00%
N/A
EPS Growth
N/A
N/A
EPS
0.03
N/A
Revenue
$330,153,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$166.67
N/A
Revenue Growth
6.03
N/A
52 Week Low
$1.76
$3.15
52 Week High
$5.59
$5.27

Technical Indicators

Market Signals
Indicator
SND
CNTN
Relative Strength Index (RSI) 68.80 27.87
Support Level $1.92 $3.15
Resistance Level $5.59 $4.78
Average True Range (ATR) 0.21 0.29
MACD 0.14 -0.08
Stochastic Oscillator 89.20 3.68

Price Performance

Historical Comparison
SND
CNTN

About SND Smart Sand Inc.

Smart Sand Inc. is a fully integrated frac sand company providing mine-to-well site proppant supply and logistics. It produces Northern White frac sand for enhanced hydrocarbon recovery in oil and gas wells. The company offers products like Smart System, SmartBelt, SmartDepot Silo, and SmartPath Loader. It is expanding into industrial markets, including glass, ceramics, and renewable energy, while its main revenue comes from sand sales and logistics.

About CNTN Canton Strategic Holdings Inc. Common Stock

Canton Strategic Holdings Inc is engaged in activities related to Canton Network, including the use of Canton Coin, to support blockchain-based infrastructure and the digitization of financial market processes. The company also operates a validator node on the Canton Network to facilitate transaction validation and network operations. It also operates a clinical-stage biotech research and development arm. Its flagship clinical asset, GV104, is being developed for a specific indication for respiratory and/or nervous system depression in military personnel and chemical incident responders. The expanded pipeline includes other indications for GV104 and GV023, an approach to autoimmune diseases as well as an early-stage multispecific biologic platform.

Share on Social Networks: